Notification of Transactions
In brief · summary, not quotable
Executive Directors Justin Ash and Harbant Samra exercised vested share awards on 18 May 2026.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your SPI notes
The Company announces that, on 18 May 2026, the Executive Directors of the Company, exercised vested awards as follows:
- Justin Ash exercised both his:
- Long Term Incentive Plan awards in the Company that were granted on 18 March 2021 (the 2021 LTIP awards). 2021 LTIP awards were subject to certain performance metrics that were measured over a three-year period and full details of the outcomes of these were reported in the Company's 2023 Annual Report and Accounts. On vesting in March 2024, the 2021 LTIP awards were subject to a further two-year holding period which ended on 19 March 2026; and
- Deferred Share Bonus Plan awards that were granted on 15 March 2023 (the 2023 DSBP awards). 2023 DSBP awards were subject to a three-year holding period which ended on 15 March 2026; and
- Harbant Samra exercised his Long Term Incentive Plan awards in the Company that were granted on 15 March 2023 (the 2023 LTIP awards). 2023 LTIP awards were subject to certain performance metrics that were measured over a three-year period and full details of the outcomes of these were reported in the Company's 2025 Annual Report and Accounts.
Following the exercise by the Directors of these awards over ordinary shares in the Company and after the satisfaction of taxes due, both decided to retain the balance of ordinary shares as follows:
| Share plan and type of award | Shares vested and exercised | Shares retained following satisfaction of taxes due | |
|---|---|---|---|
| Justin Ash | 2021 LTIP (in the form of nil-cost options) | 547,061 | 289,942 |
| Justin Ash | 2023 DSBP (in the form of nil-cost options) | 116,473 | 61,730 |
| Total number of shares retained | 351,672 |
Following the transactions, Justin Ash holds 1,652,131 ordinary shares in the Company.
| Share plan and type of award | Shares vested and exercised | Shares retained following satisfaction of taxes due | |
|---|---|---|---|
| Harbant Samra | 2023 LTIP (in the form of nil-cost options) | 37,463 | 19,855 |
| Total number of shares retained | 19,855 |
Following the transactions, Harbant Samra holds 74,932 ordinary shares in the Company.
Name of contact and telephone number for queries:
Mantraraj Budhdev
Group General Counsel, Chief People Officer and Company Secretary
Spire Healthcare Group plc
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Justin Ash | |
| 2 | Reason for the notification | ||
| a) | Position/status | Chief Executive Officer | |
| b) | Initial notification /Amendment | Initial notification | |
| a) | Name | Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350 | |
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each GB00BNLPYF73 | |
| b) | Nature of the transaction | Exercise of nil-cost options over ordinary shares vested under the Spire Healthcare Group plc Long Term Incentive Plan. Following the exercise by Mr Ash of his award over 547,061 ordinary shares and after the satisfaction of taxes due, a balance of 289,942 ordinary shares were transferred to him, which he has retained. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Nil | 289,942 | ||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2026-05-18 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Justin Ash | |
| 2 | Reason for the notification | ||
| a) | Position/status | Chief Executive Officer | |
| b) | Initial notification /Amendment | Initial notification | |
| a) | Name | Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350 | |
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each GB00BNLPYF73 | |
| b) | Nature of the transaction | Exercise of nil-cost options over ordinary shares vested under the Spire Healthcare Group plc Deferred Share Bonus Plan. Following the exercise by Mr Ash of his award over 116,473 ordinary shares and after the satisfaction of taxes due, a balance of 61,730 ordinary shares were transferred to him, which he has retained. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Nil | 61,730 | ||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2026-05-18 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Harbant Samra | |
| 2 | Reason for the notification | ||
| a) | Position/status | Chief Financial Officer | |
| b) | Initial notification /Amendment | Initial notification | |
| a) | Name | Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350 | |
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each GB00BNLPYF73 | |
| b) | Nature of the transaction | Exercise of nil-cost options over ordinary shares vested under the Spire Healthcare Group plc Long Term Incentive Plan. Following the exercise by Mr Samra of his award over 37,463 ordinary shares and after the satisfaction of taxes due, a balance of 19,855 ordinary shares were transferred to him, which he has retained. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Nil | 19,855 | ||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2026-05-18 | |
| f) | Place of the transaction | Outside a trading venue |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.